Pharmaceutical Cold Storage Warehousing Market

Over 30,000 pallet positions, split between 2–8 °C, 15–25 °C and −20 °C rooms, fill the 27,200 m² GMP and GDP compliant hub that UPS Healthcare announced in Giessen, Germany on 10 April 2023, and that building is a fair unit of account for the whole Pharmaceutical Cold Storage Warehousing market. Douglas Insights counts 12.15 million occupied GMP temperature-controlled pallet positions worldwide in 2025, each earning USD 1,245.3 a year in storage, handling and service fees, so 12.15 million × USD 1,245.3 = USD 15.13 billion. Pallet positions grow 4.71% a year and revenue per position 2.26%, which lifts revenue to USD 29.98 billion in 2035, a 7.08% CAGR. The model sits beside our other pharmaceutical logistics and cold chain studies and is built to the Douglas Insights research methodology.

How many GMP pallet positions does pharmaceutical cold storage warehousing actually rent out?

About 12.15 million occupied positions in 2025, held in qualified, temperature-mapped rooms run under GDP or GMP. Four bands make up the pharmaceutical cold storage count: controlled room temperature at 15–25 °C, refrigerated at 2–8 °C, frozen at roughly −15 to −25 °C, and ultra-cold and cryogenic at −60 °C and below. Controlled room temperature rooms hold 7.95 million positions. Refrigerated rooms hold 3.49 million, frozen 0.53 million and ultra-cold and cryogenic just 0.18 million.

Three kinds of operator are counted: third-party logistics providers, pharmaceutical wholesalers and manufacturer-run distribution centres, with in-house space valued at what a contract operator would charge for it. Revenue covers pallet storage, handling and pick-pack, secondary packaging and labelling, and clinical trial depots run inside the warehouse. Unmapped ambient sheds sit outside the count. So do hospital pharmacy fridges, cold transport and the shipping boxes and data loggers sized in the Cold Chain Temperature Monitoring Labels Market report.

Why are biologics, obesity injectables and cell therapies lifting demand for 2–8 °C and cryogenic pallet space?

Four forces add 4.71 points a year to GMP pallet-position demand, and the refrigerated and cryogenic bands take more than their share. Each is quantified below, with its contribution to the volume leg in percentage points, and the four add up exactly to the 4.71% growth in occupied pharmaceutical cold storage positions.

Underlying medicine volume contributes 1.62 points. The IQVIA Institute’s February 2026 outlook puts manufacturer-level medicine spending above USD 2.6 trillion by 2030, rising 5–8% a year, with oncology, immunology, diabetes and obesity drugs as the largest contributors. Stock follows sales. At a 72-day finished-goods cover, every extra USD 1 billion of annual sales parks about USD 197 million of product in a GMP warehouse at any moment.

The shift from tablets to injectables adds 1.48 points, almost all of it in the refrigerated band. Monoclonal antibodies, insulin and the obesity and diabetes injectables named by IQVIA travel at 2–8 °C, so every share point they take from tablets moves stock into a refrigerated room. In the model, refrigerated revenue therefore grows 7.86% a year against 4.13% for controlled room temperature.

Compliance upgrades add 0.96 points. The FDA let the Drug Supply Chain Security Act exemption for connected wholesale distributors expire on 27 August 2025 and for larger dispensers on 27 November 2025, and distributors used those deadlines to consolidate stock into validated, serial-ready space. In the model, plain ambient sheds that never carried a temperature map are requalified as 15–25 °C rooms, and each conversion enters the pallet count for the first time.

Advanced therapies and trials add 0.65 points from a small base. DHL Group bought CRYOPDP on 31 March 2025, a specialist active in 15 countries handling over 600,000 clinical and cell-therapy shipments a year, and it described the deal as part of its Pharma Specialized Network. The same calculus shaped the Giessen hub opened in April 2023: storage down to −20 °C sat in the design from day one. Ultra-cold positions are few, 0.18 million worldwide, yet each earns more than ten times a controlled room temperature pallet.

Price per position carries the rest of the 7.08% revenue path, and it is a pharmaceutical cold storage story too, because colder rooms bill more per pallet. A colder mix adds 1.21 points, serialisation and excursion handling 0.58 points and energy and wage pass-through 0.47 points, which together make up the 2.26% price leg. The pack serial numbers these warehouses scan at receipt and dispatch are created by the systems sized in our Pharmaceutical Serialisation and Track-and-Trace Software Market report.

Which bottlenecks in qualification, power and staffing slow new GMP cold rooms?

Three constraints remove 0.96 points a year from an unconstrained 5.67% pallet-position path, which is why pharmaceutical cold storage capacity grows 4.71%, not faster.

Qualification lead time costs 0.41 points. A new GMP cold room cannot take product until it has been temperature-mapped across seasons, its monitoring validated and its alarm response tested, which the EU guidelines on Good Distribution Practice of 5 November 2013 require before use. Giessen was announced as a 30,000-position site, but positions enter the count only once qualified.

Power costs 0.33 points. Refrigeration plant, redundant compressors and backup generators raise the capital cost of a 2–8 °C pallet position well above an ambient one, and operators delay marginal rooms when electricity contracts reprice.

People cost 0.22 points. GDP requires a named responsible person and trained handlers, and DHL reported more than 40 full-time pharmacists across its Asia Pacific network in 2025. Short. Scarce. Expensive.

Which temperature band makes the money in pharmaceutical cold storage warehousing, and which grows fastest?

Controlled room temperature storage earns the most today, 41.9% of 2025 revenue, but refrigerated storage overtakes it before 2035 and ultra-cold storage grows fastest at 12.24% a year.

Controlled room temperature storage is worth USD 6.34 billion because 65.4% of all occupied pallets sit at 15–25 °C, yet at USD 799 a position its 4.13% growth trails the rest. Refrigerated storage, USD 5.99 billion, holds 28.7% of positions and earns USD 1,714 each, more than double the room temperature rate; it reaches USD 12.77 billion by 2035 on antibody and obesity-injectable volume. Frozen storage at USD 1.27 billion serves plasma fractions and some vaccines, with 0.53 million positions billing about USD 2,398 a year. Ultra-cold and cryogenic storage, USD 1.53 billion, earns 10.1% of revenue from 1.5% of positions. Douglas Insights expects refrigerated revenue of USD 12.77 billion in 2035 to beat room temperature by USD 3.27 billion.

Ultra-cold and cryogenic storage is the fastest-growing band, at 12.24% a year to USD 4.85 billion. Vapour-phase nitrogen tanks and −80 °C freezer banks cost more per position than any room, and autologous cell therapies cannot be pooled across patients, so each new approval adds dedicated positions rather than filling spare ones.

Do third-party logistics providers, wholesalers or drug makers hold more pharmaceutical cold storage?

Third-party logistics providers earn 46.3% of 2025 pharmaceutical cold storage warehousing revenue, USD 7.01 billion across about 5.63 million positions. Pharmaceutical wholesalers account for 31.2%, or USD 4.72 billion, mostly inside national distribution centres in North America and Europe. Manufacturer-run distribution centres hold the remaining 22.5%, USD 3.40 billion at contract-equivalent rates, and that slice shrinks as drug makers hand launches to specialists.

The handover is visible in tenders. The UK Health Security Agency published a notice on 22 December 2025 for storage and distribution of ambient, chilled, frozen and ultra-low temperature vaccines worth £545.7 million before VAT over 2027–2033, with extensions to 2037.

Where are GMP cold pallet positions concentrated, from North America to Singapore?

North America leads with 38.6% of 2025 revenue, USD 5.84 billion, growing 6.41% a year to USD 10.87 billion on the largest biologics bill in the world. Europe follows at 29.3%, USD 4.43 billion, growing 5.81% to USD 7.80 billion; its GDP regime is mature, so growth comes from upgrades rather than new space. Asia Pacific, USD 3.45 billion, is the fastest-growing region at 9.12% a year to USD 8.26 billion, because IQVIA expects China’s medicine use to nearly double by 2030 and Singapore keeps adding GMP rooms. DHL alone reported over 80 facilities and 700,000 m² of compliant warehouse space across 13 Asia Pacific countries in April 2025.

Latin America contributes USD 771.7 million, growing 7.43% to USD 1.58 billion as Brazil and Mexico expand biologics coverage. The Middle East adds USD 393.4 million at 8.69%, as Gulf states import more refrigerated biologics. Africa is the wildcard: USD 242.1 million in 2025, rising 8.86% a year to USD 565.9 million, with vaccine-programme funding as the swing factor for pharmaceutical cold storage there.

Which logistics companies control the largest GMP cold storage footprints?

DHL Supply Chain leads with a 7.5% share of 2025 pharmaceutical cold storage warehousing revenue, Douglas Insights estimates, and the top three operators hold 15.6%. The rest is spread across wholesalers, regional specialists and manufacturer-run sites.

DHL’s lead rests on scale: over EUR 5 billion of life sciences and healthcare revenue in 2024 and a EUR 2 billion investment plan announced on 7 April 2025, half of it aimed at the Americas. UPS Healthcare built its position from the Giessen hub and from completing the USD 1.6 billion purchase of Andlauer Healthcare Group, announced 3 November 2025, which added a Canadian temperature-controlled network. Kuehne+Nagel relies on certified KN PharmaChain sites. Cencora’s World Courier wins on cryogenic depots for cell therapy, the end of the market served by Cell and Gene Therapy CDMO Services Market producers. DSV inherited Schenker’s healthcare warehouses on 30 April 2025. Movianto runs the UK Health Security Agency vaccine store, whose contract value was modified from £53.3 million to £174.1 million.

How much does a 2–8 °C pallet position cost a drug maker per month?

Published US rate cards put a refrigerated 2–8 °C pallet at USD 58–135 a month for storage alone, against USD 32–58 for a 15–25 °C cGMP pallet. Frozen pallets list at USD 85–185 a month. Ultra-low freezer positions run USD 240–520 and vapour-phase cryogenic positions USD 420–850.

Storage is only part of the pharmaceutical cold storage bill. Receiving inspection, pick-pack, labelling and excursion investigations add about 48% on top in the model, which turns the storage midpoints into USD 799 a year for room temperature, USD 1,714 for refrigerated, USD 2,398 for frozen and USD 8,347 for ultra-cold and cryogenic positions. Weighted by occupancy, that gives USD 1,245.3 a position.

A public tender checks the figure. NHS National Services Scotland sought at least 235 refrigerated and 33 ambient pallets for flu vaccine storage and distribution, valued at £2.5 million over up to 72 months: about £129.6 per pallet a month, or £1,555 a year including delivery.

Which GDP and DSCSA rules must a pharmaceutical cold storage warehouse comply with?

Two rulebooks govern every pharmaceutical cold storage room: the EU GDP guidelines of 2013 and the US Drug Supply Chain Security Act, phased in to 27 November 2026.

The EU Guidelines of 5 November 2013 on Good Distribution Practice were published in the Official Journal on 23 November 2013.

The EU guidelines require temperature mapping before a storage area is used, calibrated monitoring and investigation of every deviation. In the US, the FDA’s DSCSA exemption schedule ended the stabilisation period on 27 November 2024, then let connected-partner exemptions expire for manufacturers on 27 May 2025 and wholesalers on 27 August 2025, with small dispensers following on 27 November 2026. Serial data handling for cold storage operators is sized in the Pharmaceutical Serialisation and Track-and-Trace Software Market report.

What if biologic launches stall, or cell therapies scale faster, before 2035?

Pharmaceutical cold storage warehousing lands between USD 23.13 billion and USD 36.80 billion in 2035, with USD 29.98 billion as the base case.

In the slower case, pallet positions grow 3.12% and price 1.18%, a 4.34% revenue path to USD 23.13 billion. Biologic launches slip, obesity injectables move to oral forms and energy costs squeeze contract renewals. In the faster case, positions grow 6.04% and price 3.07%, a 9.30% path to USD 36.80 billion, with cell therapies scaling and manufacturers handing more launches to operators of the Giessen kind.

Volume is the lever that matters. A single extra point of pallet-position growth a year adds USD 2.99 billion to the 2035 total. Rival forecasts sit between 3.5% and 6.9% a year; the 7.08% base case sits just above that band because it prices the colder mix.

Douglas Exclusive: the GMP pallet-position ledger

Douglas Insights tallies 4 named GMP hubs that publish both floor area and pallet count, and finds density ranges from 0.75 to 1.71 positions per m², averaging 1.19.

The ledger converts disclosed footprints into pallets. DHL’s 2.5 million m² and UPS Healthcare’s 1.58 million m² come to 4.08 million m², or about 4.85 million positions at 1.19 a square metre. That equals 33.5% of the 14.46 million positions of global capacity implied by 84% occupancy. Their revenue share is only 12.7%.

The gap is the finding. Large network floors carry hospital supply, devices and cross-dock space that earns transport rather than storage fees, so floor area overstates pharmaceutical cold storage power by roughly 2.6 times. Buyers comparing tenders should ask for qualified positions by band, not square metres.

How we counted 12.15 million GMP pallet positions, and how closely do the cross-checks agree?

Demand side first: USD 1.90 trillion of 2025 medicine spending, back-cast from IQVIA’s USD 2.6 trillion for 2030 at 6.5%, times 72 days of cover gives USD 374.3 billion of stock. At USD 30,800 a pallet, that is 12.15 million occupied positions.

Price came next. Storage midpoints for 4 bands, times 12 months, times a 1.48 service multiplier, weighted by a 65.4/28.7/4.4/1.5 position mix, give USD 1,245.3. The arithmetic: 12.15 million × USD 1,245.3 = USD 15.13 billion across 6 regional models.

Three cross-checks follow. The NHS Scotland tender implies £1,555 a pallet-year including delivery, about USD 1,975 at 1.27 dollars per pound, or 1.6 times the USD 1,245.3 rate. Lineage’s SEC filing shows food-grade storage at USD 63.76 per pallet a quarter, under a third of the pharmaceutical storage-only rate. Rival estimates for 2025 run near USD 17.7 billion, 17% above this figure, a gap Douglas Insights puts down to wider scope definitions.

Sources

1. UPS Healthcare UPS Healthcare opens first dedicated facility in Germany (Giessen) (2023)
2. UPS UPS acquires Andlauer Healthcare Group for USD 1.6 billion (2025)
3. DHL Group DHL Group to invest EUR 2 billion in DHL Health Logistics (2025)
4. DHL Group DHL Group acquires CRYOPDP from Cryoport (2025)
5. European Commission, Official Journal Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01) (2013)
6. US FDA DSCSA waivers and exemptions beyond stabilization period (2024)
7. UK Health Security Agency, Find a Tender Storage and distribution of vaccines and medicines (C208046) (2025)
8. NHS National Services Scotland, Find a Tender Storage and distribution of seasonal influenza vaccines (2023)
9. IQVIA Institute Global Medicine Use Trends 2026 (2026)
10. US SEC EDGAR Lineage Q3 2025 earnings release (Form 8-K) (2025)